Poor formulation information in published pediatric drug trials

Pediatrics

Volumn 116, Issue 4, 2005, Pages

  Standing, Joseph F ^a,b   Khaki, Zahra F ^a   Wong, Ian C K ^a,b,c,d  

^a UNIVERSITY OF LONDON   (United Kingdom)

^b GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d WC1N 1AX   (United Kingdom)

Author keywords

Child (under 12 years); Clinical trial; Dosage forms; Literature review; Pediatrics; Pharmaceutical preparations

Indexed keywords

AMODIAQUINE; AZITHROMYCIN; CHLORPROGUANIL PLUS DAPSONE; DIHYDROARTEMISININ; DIMETHYLGLYCINE; EFAVIRENZ; FOLIC ACID; ITRACONAZOLE; LEVOTHYROXINE; NELFINAVIR; NICOTINAMIDE; OLPADRONIC ACID; OMEPRAZOLE; PIPERAQUINE; PREDNISOLONE; RETINOL; SERTRALINE; TRIMETHOPRIM; VITAMIN D; WARFARIN; DRUG;

ACCURACY; ARTICLE; CLINICAL TRIAL; DRUG ABSORPTION; DRUG CAPSULE; DRUG DOSAGE FORM; DRUG FORMULATION; DRUG INFORMATION; DRUG RESEARCH; HUMAN; INFORMATION PROCESSING; INFORMATION RETRIEVAL; METHODOLOGY; PRIORITY JOURNAL; REPRODUCIBILITY; TABLET; VALIDITY; CHILD; PEDIATRICS; PUBLICATION; PUBLISHING; STANDARD;

CHILD; CLINICAL TRIALS; DOSAGE FORMS; HUMANS; PEDIATRICS; PERIODICALS; PHARMACEUTICAL PREPARATIONS; PUBLISHING; REPRODUCIBILITY OF RESULTS;

EID: 33644682179     PISSN: 00314005     EISSN: 00314005     Source Type: Journal    
DOI: 10.1542/peds.2005-0327     Document Type: Article

References (14)

1. Czyzewski DI, Runyan DR, Lopez MA, Calles NR. Teaching and maintaining pill swallowing in HIV-infected children. AIDS Read. 2000;10:88-94
2. Schirm E, Tobi H, de Vries TW, Choonara I, De Jong-van den Berg LTW. Lack of appropriate formulations of medicines for children in the community. Acta Paediatr. 2003;92:1486-1489
3. Breitkreutz J, Wessel T, Boos J. Dosage forms for peroral drug administration to children. Paediatr Perinal Drug Ther. 1999;3:25-33
4. Teng J, Song CK, Williams RL, Polli JE. Lack of medication dose uniformity in commonly split tablets. J Am Pharm Assoc (Wash). 2002;42:195-199
5. Notterman DA, Nardi M, Saslow JG. Effect of dose formulation on Isoniazid absorption in two young children. Pediatrics. 1986;77:850-852
6. ICH Steering Committee. ICH Harmonised Tripartite Guideline. Clinical Investigation of Medicinal Products in the Paediatric Population E11; 2000. Available at: www.ich.org/MediaServer.jser?@_ID=487&@_MODE=GLB
7. Standing JF, Wong IC. Chlorproguanil-dapsone for malaria [letter]. Lancet. 2004;364:1752-1753
8. European Medicines Agency. Concept Paper on the Development of Committee for Proprietary Medicinal Products (CPMP) Guidance on Formulations of Choice for the Paediatric Population. London, United Kingdom: European Medicines Agency; 2003
9. Birken CS, Parkin PC. In which journals will pediatricians find the best evidence for clinical practice? Pediatrics. 1999;103:941-947
10. 2002 Journal Citation Reports, Science Edition. Philadelphia, PA: Thomson ISI; 2003
11. Arulanantham K, Genel M. Central nervous system toxicity associated with ingestion of propylene glycol. J Pediatr. 1978;93:515-516
12. Bigeard L. The role of medication and sugars in pediatric dental patients. Dent Clin N Am. 2000;44:443-456
13. Pawar S, Kumar A. Issues in the formulation of drugs for oral use in children: role of excipients. Paediatr Drugs. 2002;4:371-379
14. Rabiu F, Forsey P, Patel S. Preservatives can produce harmful effects in paediatric drug preparations. Pharm Pract. 2004;14:101-108